Warut Kengkittipat

Mr. Warut Kengkittipat


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2025 in Animals
Verified
Journal Article
Open access
PDF file
Warut KengkittipatWarut Kengkittipat
Warut Kengkittipat
Manoj Tukaram KambleManoj Tukaram Kamble
Manoj Tukaram Kamble
SKsirikorn kitiyodom
sirikorn kitiyodom
JYJakarwan Yostawonkul
Jakarwan Yostawonkul
Gotchagorn SawatphakdeeGotchagorn Sawatphakdee
Gotchagorn Sawatphakdee
NPNopadon Pirarat
Nopadon Pirarat
The increasing demand for sustainable disease management in aquaculture has intensified interest in plant-based therapeutics. This study evaluated the formulation and efficacy of andrographolide-loaded nanostructured lipid carriers (AND-NLCs) in Nile tilapia (Oreochromis niloticus) challenged with Streptococcus agalactiae ENC06. AND-NLCs were prepared by the phase-inversion technique and characterized by dynamic light scattering, transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), and in vitro release profiling. Antibacterial activity was assessed by measuring inhibition zone diameters, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). Growth performance, feed utilization, hepatosomatic index (HSI), and disease resistance were evaluated over a 60-day feeding trial. The AND-NLCs exhibited an optimal particle size (189.6 nm), high encapsulation efficiency (90.58%), sustained release, and structural stability. Compared to the free AND and control group, AND-NLC supplementation significantly improved growth, feed efficiency, HSI, and positive allometric growth. It also enhanced survival (73.3%) and relative percent survival (RPS = 65.6%) following S. agalactiae ENC06 infection. Antibacterial efficacy and physiological responses showed positive correlations with nanoparticle characteristics. These findings suggest that AND-NLCs enhance bioavailability and therapeutic efficacy, supporting their potential as a functional dietary additive to promote growth and improve disease resistance in tilapia aquaculture.

20 July 2026 in Veterinary World
Verified
Journal Article
Open access
PDF file
Warut KengkittipatWarut Kengkittipat
Warut Kengkittipat
Manoj Tukaram KambleManoj Tukaram Kamble
Manoj Tukaram Kamble
SKsirikorn kitiyodom
sirikorn kitiyodom
JYJakarwan Yostawonkul
Jakarwan Yostawonkul
Gotchagorn SawatphakdeeGotchagorn Sawatphakdee
Gotchagorn Sawatphakdee
NPNopadon Pirarat
Nopadon Pirarat
Background and Aim: Streptococcosis caused by Streptococcus agalactiae represents a major constraint to Nile tilapia (Oreochromis niloticus) aquaculture, resulting in substantial economic losses. Curcumin (CUR) possesses antioxidant, antimicrobial, and immunomodulatory properties, but its practical application is limited by poor aqueous solubility and low bioavailability. This study aimed to develop CUR encapsulated in nanostructured lipid carriers (CUR-NLCs) and evaluate their effects on growth performance, feed utilization efficiency, and resistance against S. agalactiae infection in Nile tilapia. Materials and Methods: CUR-NLCs were synthesized using a phase-inversion compositional technique and characterized for particle size, polydispersity index, zeta potential, encapsulation efficiency, and release behavior. A 60-day feeding trial was conducted using four dietary treatments: a control diet, a free CUR diet (2000 mg/kg feed), CUR-NLCs containing an equivalent amount of CUR, and blank nanostructured lipid carriers. Growth performance, feed utilization indices, hepatosomatic index, and length–weight relationships were evaluated. Antibacterial activity against S. agalactiae isolates was determined, followed by experimental challenge with strain ENC06 to assess survival responses. Results: CUR-NLCs exhibited favorable physicochemical characteristics, including a mean particle size of 215.6 nm, a low polydispersity index (0.145), and a high encapsulation efficiency (98.79%), along with sustained-release properties. CUR-NLCs produced larger inhibition zones against S. agalactiae than free CUR. Fish receiving the CUR-NLC diet demonstrated significantly higher final body weight, weight gain, specific growth rate, feed intake, and protein efficiency ratio than the control group (p < 0.05). Positive allometric growth (b = 3.278) and improved relative condition factor were observed in CUR-NLC-fed fish. Following bacterial challenge, CUR-NLC supplementation resulted in the lowest mortality (11.1%), highest survival (88.9%), and highest relative percent survival (82.4%). Cox proportional hazards analysis indicated an approximately 86% reduction in mortality risk compared with infected controls. Conclusion: Dietary administration of CUR encapsulated in nanostructured lipid carriers improved growth performance, feed utilization efficiency, and post-challenge survival of Nile tilapia. These findings demonstrate that CUR-NLCs represent a promising phytobiotic-based nutritional strategy for enhancing fish health and promoting sustainable tilapia aquaculture. Keywords: aquaculture, curcumin, disease resistance, feed efficiency, nanostructured lipid carriers, Nile tilapia, streptococcosis, sustained release.